Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI ^BETAClose X

Barclays disclosed on 6 Nov 2026 that its position in Advanced Medical Solutions Group PLC comprises 7,458,148 shares (3.37%) held and 912,987 shares (0.41%) via cash-settled derivatives, giving aggregate long interests of 8,371,135 shares (3.79%) and aggregate short positions of 8,369,855 shares (3.79%), leaving a net long of 1,280 shares (~0.00%). On 5 Nov 2026 Barclays executed market trades netting a purchase of 40,414 shares at c.£2.83 per share (range £2.825–£2.845). No indemnities or related arrangements were disclosed.

Disclaimer*

Companies

Barclays (BARC)
Advanced Medical Solutions Group (AMS)

UK 100

Latest directors dealings

5 hours ago Luceco
5 hours ago Helios Towers
5 hours ago Wise Class A
6 hours ago EDX Medical Group Plc
6 hours ago Naked Wines

All directors dealings today

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				ADVANCED MEDICAL SOLUTIONS GROUP PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				05 Nov 2026
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				5p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			7,458,148	3.37%	913,376	0.41%
(2)	Cash-settled derivatives:
				912,987	0.41%	7,456,479	3.37%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			8,371,135	3.79%	8,369,855	3.79%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
5p ordinary		Purchase		78,935		2.8287 GBP
5p ordinary		Purchase		21,133		2.8345 GBP
5p ordinary		Purchase		19,982		2.8300 GBP
5p ordinary		Purchase		10,641		2.8308 GBP
5p ordinary		Purchase		4,721		2.8328 GBP
5p ordinary		Purchase		3,000		2.8250 GBP
5p ordinary		Purchase		2,780		2.8350 GBP
5p ordinary		Purchase		388		2.8325 GBP
5p ordinary		Purchase		149		2.8332 GBP
5p ordinary		Purchase		21		2.8450 GBP
5p ordinary		Sale		56,645		2.8300 GBP
5p ordinary		Sale		30,487		2.8275 GBP
5p ordinary		Sale		8,946		2.8254 GBP
5p ordinary		Sale		5,258		2.8328 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
5p ordinary		SWAP		Increasing Short		1,205	2.8350 GBP
5p ordinary		SWAP		Increasing Short		1,575	2.8350 GBP
5p ordinary		CFD		Decreasing Long		198	2.8324 GBP
5p ordinary		CFD		Increasing Short		18,351	2.8353 GBP
5p ordinary		SWAP		Decreasing Long		4,721	2.8332 GBP
5p ordinary		SWAP		Increasing Short		2,231	2.8300 GBP
5p ordinary		SWAP		Increasing Short		10,077	2.8300 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercise
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				06 Nov 2026
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI BETAClose X

Companies

UK 100

Latest directors dealings

Summary by AI ^BETAClose X